We are live on ! Find out more
KC

Kryger Capital Portfolio holdings

AUM $1.41B
1-Year Est. Return 86.31%
This Fund
S&P 500
This Quarter Est. Return
+11.41%
1 Year Est. Return
+86.31%
3 Year Est. Return
+420.13%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$1.41B
AUM Growth
+$120M
Cap. Flow
+$75.8M
Cap. Flow %
5.36%
Top 10 Hldgs %
67.08%
Holding
104
New
54
Increased
17
Reduced
5
Closed
28

Top Buys

Rank Stock Value
1
KVUE icon
Kenvue
KVUE
+$83.7M
2
WBD icon
Warner Bros
WBD
+$68.3M
3
DAWN
Day One Biopharmaceuticals
DAWN
+$54.9M
4
GTLS
Chart Industries
GTLS
+$52.7M
5
PEN icon
Penumbra
PEN
+$52.1M

Top Sells

Rank Stock Value
1
CFLT
Confluent
CFLT
+$113M
2
EXAS
Exact Sciences
EXAS
+$103M
3
CYBR
CyberArk
CYBR
+$90.7M
4
FYBR
Frontier Communications
FYBR
+$83.3M
5
DAY
Dayforce
DAY
+$77.8M

Sector Composition

Rank Sector Weight
1 Industrials 23.19%
2 Healthcare 22.98%
3 Financials 15.02%
4 Communication Services 13.32%
5 Technology 9.38%

No holdings matched the selected filter criteria.

1 2 3 4 5

Similar funds

EWS
Evergreen Wealth Solutions Williamsport, Pennsylvania $1.41B AUM 18.71% 1-Year Est. Return
CBA
Coastal Bridge Advisors Westport, Connecticut $1.41B AUM 24.15% 1-Year Est. Return
SCM
Spyglass Capital Management San Francisco, California $1.41B AUM 7.96% 1-Year Est. Return
PTC
Philadelphia Trust Company Philadelphia, Pennsylvania $1.42B AUM 43.77% 1-Year Est. Return
QC
Quent Capital New York $1.41B AUM 22.9% 1-Year Est. Return
BC
Broadwood Capital New York $1.42B AUM 34.72% 1-Year Est. Return
EA
Efficient Advisors Mason, Ohio $1.41B AUM 13.81% 1-Year Est. Return
IAS
Insigneo Advisory Services Miami, Florida $1.41B AUM 27.46% 1-Year Est. Return

Kryger Capital's Q1 2026 Portfolio in Review

As of Q1 2026, Kryger Capital held 104 positions worth $1.41B, up 9.2% from $1.29B the previous quarter. Its ten largest holdings account for 67% of the portfolio.

Kryger Capital deployed $75.8M of net new capital in Q1 2026, opening 54 new positions and adding to 17 existing holdings. Its largest new stake was Day One Biopharmaceuticals: 3,896,485 shares worth $83.5M.

By sector, the portfolio is most concentrated in Industrials at 23% of assets, up from 20% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Daedalus Special Acquisition Corp Unit, an estimated $4.33M trimmed.

  • Kryger Capital's largest Q1 2026 buy was Day One Biopharmaceuticals: 3,896,485 shares worth $83.5M.
  • Kryger Capital added most to Kenvue in Q1 2026, an estimated $83.7M increase.
  • Kryger Capital's biggest Q1 2026 reduction was Daedalus Special Acquisition Corp Unit, cutting an estimated $4.33M.
  • Kryger Capital fully exited Confluent in Q1 2026, selling an estimated $113M.
  • Kryger Capital's ten largest holdings make up 67% of its $1.41B portfolio in Q1 2026.
  • Kryger Capital opened 54 new positions and closed 28 in Q1 2026.
  • Kryger Capital's portfolio value rose 9.2% quarter-over-quarter to $1.41B.

Based on Kryger Capital's 13F filing for Q1 2026, filed 14 May 2026.